Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
Tuberculosis (Edinb) ; 125: 101994, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-33049436

RESUMEN

OBJECTIVE: Micro-nutrients are closely related to pulmonary tuberculosis (PTB). Most patients with PTB suffer from micro-nutrients deficiency. We aimed to evaluate the efficacy of micro-nutrients support on clinical therapy and chronic inflammation in patients with PTB. METHODS: We searched Pubmed, Springer link, Web of Science, Cochrane, Wan Fang and CNKI databases for randomised controlled trials (RCTs). The patients with anti-TB treatments were divided into two groups, the control group with nutritional advice or placebo, and the experimental group with micro-nutrients support for more than 2 weeks. Two reviewers conducted data extraction and quality assessment of the studies independently, and ReviewManager 5.2 software was used to input and analyse the data. The dichotomous variable was expressed in the risk ratios (RRS) and 95% CI, the continuous data were expressed in the mean difference (MD) and 95% CI, and the heterogeneity of subgroup was evaluated by I (Kerantzas and Jacobs, Jr., 2017) [2] test. RESULTS: A total of 13 trials (2847 participants) were included. First, micro-nutrients improved sputum smears or culture negative conversion rates (OR 0.16 0.03-0.77, 2.29; MD -2.36, -4.72~-0.01, z = 1.97). Meanwhile, micro-nutrients support increased lymphocytes and decreased leukocytes, neutrophils, CRP and ESR (MD 0.20, 0.06-0.35, z = 2.78; MD -0.42, -0.65~-0.18, z = 3.48; MD -0.66, -1.12~-0.20, z = 2.82). However it had not impact on body weight, MUAC, haemoglobin, albumin or monocytes (p > 0.05). CONCLUSION: Micro-nutrients support can reduce chronic inflammation and improve sputum smears or culture conversions to contribute to anti-TB treatment.


Asunto(s)
Antituberculosos/uso terapéutico , Inmunidad Innata , Desnutrición/complicaciones , Mycobacterium tuberculosis/aislamiento & purificación , Nutrientes/farmacología , Ensayos Clínicos Controlados Aleatorios como Asunto , Tuberculosis Pulmonar/terapia , Humanos , Esputo/microbiología , Tuberculosis Pulmonar/etiología , Tuberculosis Pulmonar/microbiología
2.
J Int Med Res ; 48(5): 300060519875535, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32367748

RESUMEN

OBJECTIVE: To evaluate the clinical efficacy of Baihe Gujin decoction combined with anti-tuberculosis therapy in mitigating the symptoms of pulmonary tuberculosis and to measure the effect on the CD4+ CD25+ regulatory T cell (Treg) ratio. METHODS: This randomized study enrolled patients with pulmonary tuberculosis and randomly assigned them to one of two treatment groups: an anti-tuberculosis treatment group and a combined treatment group. Bronchoalveolar lavage was performed before and 2 weeks after treatment. The ratio of CD4+ CD25+ Treg cells and the levels of tumour necrosis factor (TNF)-α, interleukin (IL)-4, IL-6 and IL-12 in peripheral blood and bronchoalveolar lavage fluid were measured. Symptoms were recorded before and after treatment. RESULTS: A total of 100 patients were enrolled and assigned to the anti-tuberculosis (n = 58) and combined treatment groups (n = 42). In the combined treatment group, Leicester Cough Questionnaire score, erythrocyte sedimentation rate, CD4+ CD25+ Treg cell ratio in bronchoalveolar lavage fluid, cytokine levels, chest pain score and sleep disorder score were significantly decreased compared with the anti-tuberculosis treatment group after treatment. The leukocyte count, haemoglobin level, platelet and alanine aminotransferase levels did not differ significantly between the two groups after treatment. The creatinine level in the combined treatment group was significantly lower than that in the anti-tuberculosis treatment group. CONCLUSION: Baihe Gujin decoction combined with anti-tuberculosis treatment can effectively alleviate the symptoms of pulmonary tuberculosis, enhance the host immune function and protect renal function.


Asunto(s)
Antituberculosos/uso terapéutico , Medicamentos Herbarios Chinos/uso terapéutico , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/etiología , Deficiencia Yin/complicaciones , Anciano , Biomarcadores , Citocinas/metabolismo , Femenino , Humanos , Inmunofenotipificación , Masculino , Medicina Tradicional China , Persona de Mediana Edad , Linfocitos T Reguladores/efectos de los fármacos , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/metabolismo , Resultado del Tratamiento
3.
Cad. Saúde Pública (Online) ; 35(supl.3): e00074218, 2019. tab, graf
Artículo en Portugués | LILACS | ID: biblio-1019641

RESUMEN

Resumo: O objetivo deste estudo foi descrever características clínicas e sociodemográficas, estimar a incidência da tuberculose (TB), além de analisar fatores associados ao abandono e ao óbito na vigência do tratamento dos casos de TB notificados entre crianças e adolescentes indígenas, no Brasil, entre 2006-2016. Realizou-se análise da série histórica de incidência, segundo faixa etária e macrorregião e utilizou-se regressão logística multinomial para elucidar fatores associados ao abandono e ao óbito. Do total de 2.096 casos notificados, 88,2% tiveram cura, 7,2% abandonaram o tratamento e 4,6% evoluíram para óbito. Houve predomínio de casos em meninos de 15-19 anos e maior proporção de óbitos (55,7%) em < 4 anos. Considerando o conjunto de crianças e adolescentes indígenas com TB no Brasil, a incidência média foi 49,1/100 mil, variando de 21,5/100 mil a 97,6/100 mil nas regiões Nordeste e Centro-oeste, respectivamente. Os casos com acompanhamento insuficiente e regular tiveram maiores chances de abandono (OR = 11,1; IC95%: 5,2-24,8/OR = 4,4; IC95%: 1,9-10,3) e óbito (OR = 20,3; IC95%: 4,9-84,9/OR = 5,1; IC95%: 1,2-22,7). Os casos em retratamento (OR = 2,4; IC95%: 2,08-8,55) e com anti-HIV positivo (OR = 8,2; IC95%: 2,2-30,9) também mostraram-se associados ao abandono. As formas clínicas extrapulmonar (OR = 1,8; IC95%: 1,1-3,3) e mista (OR = 5,6; IC95%: 2,8-11,4), os casos em < 4 anos (OR = 3,1; IC95%: 1,5-6,4) e os casos provenientes das regiões Norte (OR = 2,8; IC95%: 1,1-7,1) e Centro-oeste (OR = 2,8; IC95%: 1,1-7,0) mostraram-se associados ao óbito. Acreditamos que o controle da TB em crianças e adolescentes indígenas não poderá ser alcançado sem investimentos em pesquisa e desenvolvimento e sem a redução das desigualdades sociais.


Abstract: The study aimed to describe clinical and sociodemographic characteristics, estimate incidence, and analyze factors associated with dropout and death during treatment of TB cases reported in indigenous children and adolescents in Brazil from 2006 to 2016. A historical case series was performed on incidence according to age bracket and major geographic region, and multinomial logistic regression was used to explain factors associated with treatment dropout and death. Of the 2,096 reported cases, 88.2% evolved to cure, 7.2% dropped out of treatment, and 4.6% evolved to death. There was a predominance of cases in boys 15-19 years of age and a higher proportion of deaths (55.7%) in children < 4 years. Considering indigenous children and adolescents with TB in Brazil as a whole, mean incidence was 49.1/100,000, ranging from 21.5/100,000 to 97.6/100,000 in the Northeast and Central, respectively. Cases with insufficient and irregular follow-up showed higher odds of dropout (OR = 11.1; 95%CI: 5.2-24.8/OR = 4.4; 95%CI: 1.9-10.3) and death (OR = 20.3; 95%CI: 4.9-84.9/OR = 5.1; 95%CI: 1.2-22.7). Cases in retreatment (OR = 2.4; 95%CI: 2.08-8.55) and with HIV coinfection (OR = 8.2; 95%CI: 2.2-30.9) were also associated with dropout. Extrapulmonary (OR = 1.8; 95%CI: 1.1-3.3) and mixed clinical forms (OR = 5.6; 95%CI: 2.8-11.4), age < 4 years (OR = 3.1; 95%CI: 1.5-6.4), and cases from the North (OR = 2.8; 95%CI: 1.1-7.1) and Central (OR = 2.8; 95%CI: 1.1-7.0) were associated with death. TB control in indigenous children and adolescents cannot be achieved without investments in research and development and without reducing social inequalities.


Resumen: El objetivo de este estudio fue describir características clínicas y sociodemográficas, estimar la incidencia de la tuberculosis (TB), además de analizar factores asociados al abandono y al óbito en la vigencia del tratamiento de los casos de TB, notificados entre niños y adolescentes indígenas, en Brasil entre 2006-2016. Se realizó un análisis de la serie histórica de incidencia, según la franja de edad y macrorregión y se utilizó la regresión logística multinomial para elucidar factores asociados al abandono y al óbito. Del total de 2.096 casos notificados, un 88,2% tuvieron cura, un 7,2% abandonaron el tratamiento y un 4,6% evolucionaron hacia óbito. Hubo un predominio de casos en chicos de 15-19 años y mayor proporción de óbitos (55,7%) en < 4 años. Considerando el conjunto de niños y adolescentes indígenas con TB en Brasil, la incidencia media fue 49,1/100.000, variando de 21,5/100.000 a 97,6/100.000 en las regiones Nordeste y Centro-oeste, respectivamente. Los casos con un seguimiento insuficiente y regular tuvieron mayores oportunidades de abandono (OR = 11,1; IC95%: 5,2-24,8/OR = 4,4; IC95%: 1,9-10,3) y óbito (OR = 20,3; IC95%: 4,9-84,9/OR = 5,1; IC95%: 1,2-22,7). Los casos de retorno al tratamiento (OR = 2,4; IC95%: 2,08-8,55) y con anti-VIH positivo (OR = 8,2; IC95%: 2,2-30,9) también se mostraron asociados al abandono. Las formas clínicas extrapulmonares (OR = 1,8; IC95%: 1,1-3,3) y mixta (OR = 5,6; IC95%: 2,8-11,4), los casos en < 4 años (OR = 3,1; IC95%: 1,5-6,4) y los casos procedentes de las regiones Norte (OR = 2,8; IC95%: 1,1-7,1) y Centro-oeste (OR = 2,8; IC95%: 1,1-7,0) se mostraron asociados al óbito. Creemos que el control de la TB en niños y adolescentes indígenas no se podrá alcanzar sin inversiones en investigación y desarrollo y sin la reducción de las desigualdades sociales.


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Adolescente , Adulto Joven , Pacientes Desistentes del Tratamiento/estadística & datos numéricos , Tuberculosis/epidemiología , Indígenas Sudamericanos/estadística & datos numéricos , Notificación de Enfermedades/estadística & datos numéricos , Muerte , Pacientes Desistentes del Tratamiento/etnología , Factores Socioeconómicos , Tuberculosis/diagnóstico , Tuberculosis/etnología , Tuberculosis/mortalidad , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/etiología , Tuberculosis Pulmonar/epidemiología , Brasil/epidemiología , Características de la Residencia/estadística & datos numéricos , Incidencia , Distribución por Sexo , Distribución por Edad , Continuidad de la Atención al Paciente/estadística & datos numéricos
4.
Transpl Infect Dis ; 18(5): 782-784, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27459235

RESUMEN

Donor-derived tuberculosis (TB) is an increasingly recognized complication of solid organ transplantation. We report a case of isoniazid-resistant pulmonary TB in a lung transplant recipient. The patient acquired the infection from the lung donor who was previously empirically treated with isoniazid for latent TB. The case highlights the caveat that, while adequate treatment of latent TB with isoniazid is presumed, meticulous screening of donors is required.


Asunto(s)
Aloinjertos/microbiología , Antibacterianos/uso terapéutico , Antituberculosos/uso terapéutico , Fibrosis Quística/cirugía , Farmacorresistencia Bacteriana , Isoniazida/uso terapéutico , Tuberculosis Latente/tratamiento farmacológico , Trasplante de Pulmón/efectos adversos , Mycobacterium tuberculosis/fisiología , Tuberculosis Pulmonar/etiología , Adulto , Antibacterianos/administración & dosificación , Profilaxis Antibiótica , Antituberculosos/administración & dosificación , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Líquido del Lavado Bronquioalveolar , Broncoscopía , Fibrosis Quística/genética , Femenino , Fluoroquinolonas/administración & dosificación , Fluoroquinolonas/uso terapéutico , Humanos , Terapia de Inmunosupresión/efectos adversos , Isoniazida/administración & dosificación , Pruebas de Sensibilidad Microbiana , Moxifloxacino , Mycobacterium tuberculosis/aislamiento & purificación , Pseudomonas aeruginosa/aislamiento & purificación , Rifampin/administración & dosificación , Rifampin/uso terapéutico , Donantes de Tejidos , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/microbiología
5.
20 Century Br Hist ; 26(1): 97-121, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26411063

RESUMEN

This article looks at Britain's response to the World Refugee Year (1959-60), and in particular the government's decision to allow entry to refugees with tuberculosis and other chronic illnesses. In doing so, it broke the practice established by the 1920 Aliens' Order which had barred entry to immigrants with a range of medical conditions. This article uses the entry of these sick refugees as an opportunity to explore whether government policy represented as much of a shift in attitude and practice as contemporary accounts suggested. It argues for the importance of setting the reception of tubercular and other 'disabled' refugees in 1959-61 in its very particular historical context, showing it was a case less of the government thinking differently about refugees, and more of how, in a post-Suez context, the government felt obliged to take into account international and public opinion. The work builds on and adds to the growing literature surrounding refugees and disease. It also places the episode within the specificity of the post-war changing epidemiological climate; the creation of the National Health Service; and the welfare state more broadly. In looking at the role of refugee organizations in the Year, the article also contributes to debates over the place of voluntary agencies within British society.


Asunto(s)
Regulación Gubernamental/historia , Política de Salud/historia , Refugiados/historia , Tuberculosis Pulmonar/historia , Historia del Siglo XX , Humanos , Programas Nacionales de Salud , Opinión Pública , Tuberculosis Pulmonar/epidemiología , Tuberculosis Pulmonar/etiología , Reino Unido
6.
Crit Rev Food Sci Nutr ; 55(7): 955-63, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-24915351

RESUMEN

Malnutrition and tuberculosis are both problems mostly of the developing countries. Tuberculosis can lead to malnutrition and malnutrition may predispose to tuberculosis. Poor nutrition leads to protein-energy malnutrition and micronutrients deficiencies which lead to immunodeficiency. This secondary immunodeficiency increases the host's susceptibility to infection and hence increase the risk for developing tuberculosis. Tuberculosis itself leads to reduction in appetite, nutrient malabsorption, micronutrient malabsorption, and altered metabolism leading to wasting and poor nutritional status. Nutritional status and dietary intake and hence nutritional status of patients get improved during antituberculosis treatment.


Asunto(s)
Antituberculosos/uso terapéutico , Países en Desarrollo , Desnutrición/complicaciones , Estado Nutricional , Tuberculosis Pulmonar/tratamiento farmacológico , Apetito/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Humanos , Micronutrientes/farmacología , Estado Nutricional/efectos de los fármacos , Factores de Riesgo , Resultado del Tratamiento , Tuberculosis Pulmonar/etiología , Tuberculosis Pulmonar/fisiopatología
8.
PLoS One ; 9(6): e100377, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24959854

RESUMEN

Primary inoculation tuberculosis is a skin condition that develops at the site of inoculation of Mycobacterium tuberculosis in tuberculosis-free individuals. This report describes the diagnosis, treatment and >1 year follow-up of 30 patients presenting with acupuncture-induced primary inoculation tuberculosis. Our data provide a deeper insight into this rare route of infection of tuberculosis. We also review effective treatment options.


Asunto(s)
Terapia por Acupuntura/efectos adversos , Tuberculosis/diagnóstico , Tuberculosis/etiología , Adulto , Anciano , Antituberculosos/uso terapéutico , Encéfalo/patología , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Articulación de la Rodilla/patología , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Piel/patología , Resultado del Tratamiento , Tuberculoma Intracraneal/diagnóstico , Tuberculoma Intracraneal/etiología , Tuberculosis/tratamiento farmacológico , Tuberculosis Cutánea/diagnóstico , Tuberculosis Cutánea/etiología , Tuberculosis Osteoarticular/diagnóstico , Tuberculosis Osteoarticular/etiología , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/etiología
9.
Kekkaku ; 88(9): 671-5, 2013 Sep.
Artículo en Japonés | MEDLINE | ID: mdl-24298694

RESUMEN

A 66-year-old man with hepatocellular carcinoma (HCC) and suspicion of lung metastasis consulted us because of an abnormal chest shadow as seen on a radiograph. He had been treated with sorafenib for 2 months. A chest CT scan showed cavitating nodules in the left upper lobe that were present before therapy with sorafenib, and infiltrative shadows in the subpleural areas of the right upper lobe. The shadows were diagnosed, at least in part, as pulmonary tuberculosis by using a nucleic acid amplification test for Mycobacterium tuberculosis in the sputum that yielded a positive result. Treatment with antituberculosis drugs resulted in a good clinical response. However, the patient died of HCC. We concluded that the nodule in the right upper lobe was old pulmonary tuberculosis, because it did not change during the course of the disease and because the cavities in the left upper lobe were active lesions. Sorafenib is a molecularly targeted agent that has been proven effective for treating advanced HCC with extrahepatic metastasis. It may also cause necrosis within lung metastases as an anti-tumor effect. Therefore, pulmonary tuberculosis, including reactivation, should be considered in the differential diagnosis when treating a patient with sorafenib.


Asunto(s)
Antineoplásicos/efectos adversos , Carcinoma Hepatocelular/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Niacinamida/análogos & derivados , Compuestos de Fenilurea/efectos adversos , Tuberculosis Pulmonar/etiología , Anciano , Humanos , Masculino , Niacinamida/efectos adversos , Sorafenib
10.
Cad Saude Publica ; 27(1): 190-4, 2011 01.
Artículo en Portugués | MEDLINE | ID: mdl-21340118

RESUMEN

The objective of this note is to present preliminary results of an ongoing study of Xavánte perspectives regarding tuberculosis (TB) and their implications for treatment and control. Interviews conducted at the Pimentel Barbosa Indigenous Reserve, Mato Grosso State, Brazil, revealed multiple explanatory models for the illness. The Xavánte emphasize sorcery (simi'õ or abzé) and microbes as principal causes of TB. Accordingly, they not only make use of phytotherapies, but also follow the chemotherapy prescribed by biomedicine. Among the Xavánte, indigenous culture is not an impediment to the execution of measures indicated by the National Tuberculosis Control Program (PNCT), since it is not in conflict with biomedicine. To the contrary, the Xavánte demonstrate interest in medical tests, allow BCG vaccinations, show up for consultations, and follow the prescribed chemotherapy. As a counterpoint, local health services do not carry out or carry out incompletely important activities prescribed by the PNCT, compromising the priorities of early detection and adequate treatment of new cases of the disease.


Asunto(s)
Características Culturales , Indígenas Sudamericanos , Tuberculosis Pulmonar/etnología , Brasil , Servicios de Salud del Indígena , Humanos , Medicina Tradicional , Tuberculosis Pulmonar/etiología , Tuberculosis Pulmonar/prevención & control
11.
Thorax ; 62(11): 1003-7, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17526677

RESUMEN

BACKGROUND: As well as its role in the regulation of calcium metabolism, vitamin D is an immunoregulatory hormone. Epidemiological evidence also suggests a link between vitamin D deficiency and tuberculosis (TB). A study was undertaken to examine serum vitamin D concentrations before treatment in patients with active TB and their contacts from the same ethnic and social background and to investigate the relative contributions of diet and sunlight exposure. METHODS: Serum vitamin D concentrations were measured before treatment in 178 patients with active TB and 130 healthy contacts. The prevalence of vitamin D deficiency and its relation to skin colour, month of estimation and TB diagnosis were determined. 35 patients and 35 frequency-matched contacts completed dietary and sun exposure questionnaires to determine the relative contribution of these to serum vitamin D concentrations. RESULTS: There was a statistically significant difference in serum vitamin D concentrations between patients and contacts (20.1 vs 30.8 nmol/l, 95% CI 7.1 to 14.3; p<0.001) and significantly more patients had severely deficient concentrations (<21 nmol/l) than controls (114/178 (64%) vs 40/130 (31%), p<0.001). There was no association between serum concentrations of vitamin D and skin pigmentation. The healthy contacts showed a predictable seasonal pattern, rising to peak concentrations in the summer months, but this response was absent in patients with TB. Dietary intake was the same in both patients with TB and contacts matched for age, sex and skin colour, but patients with TB displayed a stronger correlation between serum vitamin D concentrations and dietary intake (r = 0.42, p = 0.016) than controls (r = 0.13, p>0.1). There was no difference in sunlight exposure between the groups. CONCLUSIONS: Patients with active TB have lower serum vitamin D concentrations than contacts from similar ethnic and social backgrounds and with comparable dietary intake and sun exposure, and do not show the expected seasonal variation. These observations indicate that other factors are contributing to vitamin D deficiency in patients with TB and suggest abnormal handling of this vitamin.


Asunto(s)
Calcifediol/deficiencia , Dieta , Pigmentación de la Piel/fisiología , Luz Solar , Tuberculosis Pulmonar/etiología , Deficiencia de Vitamina D/complicaciones , Adolescente , Adulto , Anciano , Niño , Preescolar , Suplementos Dietéticos , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Recurrencia , Estaciones del Año , Tuberculosis Pulmonar/sangre , Vitamina D/administración & dosificación , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/dietoterapia
14.
Top HIV Med ; 12(5): 144-9, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15647610

RESUMEN

In the Caribbean region, the lifetime risk of active tuberculosis (TB) in purified protein derivative (PPD)-positive HIV-infected patients is 50%. Screening of individuals with cough who came to an HIV voluntary counseling and testing center in Haiti revealed active TB in 33% of patients. TB prophylaxis is effective in preventing active disease in HIV-infected individuals, and secondary prophylaxis has been shown to reduce recurrence in patients diagnosed with TB at more advanced stages of immunosuppression. Recommendations for anti-TB therapy differ according to whether antiretroviral therapy is available or not and according to whether the TB diagnosis is made while the patient is receiving antiretroviral therapy or not. This article summarizes a presentation by Jean William Pape, MD, at the first CHART Caribbean Conference on the Clinical Management of HIV/AIDS in Montego Bay, Jamaica in June 2004.


Asunto(s)
Infecciones por VIH/diagnóstico , Infecciones por VIH/prevención & control , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/prevención & control , Fármacos Anti-VIH/administración & dosificación , Antituberculosos/administración & dosificación , Región del Caribe/epidemiología , Interacciones Farmacológicas , Infecciones por VIH/epidemiología , Infecciones por VIH/etiología , Humanos , Tuberculosis Pulmonar/epidemiología , Tuberculosis Pulmonar/etiología
15.
Int J Tuberc Lung Dis ; 7(9): 820-7, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12971664

RESUMEN

Respiratory disease accounts for a substantial proportion of illness in human immunodeficiency virus-infected children. A number of interventions are available to prevent respiratory complications; these interventions may be beneficial especially in low-income countries where the burden of human immunodeficiency virus and infectious diseases are high and where antiretroviral therapy is unavailable or unaffordable. This article reviews the potential benefits and risks for interventions that are available to prevent respiratory complications including chemoprophylaxis for Pneumocystis carinii pneumonia and tuberculosis, use of immunisation for prevention of specific respiratory infections and non-specific measures including nutrition and micronutrient supplementation.


Asunto(s)
Protección a la Infancia , Países en Desarrollo , Infecciones por VIH/complicaciones , Enfermedades Respiratorias/prevención & control , Enfermedades Respiratorias/virología , Antituberculosos/administración & dosificación , Antituberculosos/uso terapéutico , Quimioprevención , Niño , Humanos , Programas de Inmunización , Isoniazida/administración & dosificación , Isoniazida/uso terapéutico , Micronutrientes , Estado Nutricional , Pobreza , Enfermedades Respiratorias/etiología , Tuberculosis Pulmonar/etiología , Tuberculosis Pulmonar/prevención & control , Tuberculosis Pulmonar/virología
16.
Indian J Med Sci ; 50(10): 365-7, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9057372

RESUMEN

In rural areas of desert of western Rajasthan crude opium is consumed with a social sanction by a notable proportion (7.1%) of adult males. It is believed that prevalence of opium addiction is high in TB cases as they may use it to suppress cough. Prevalence of opium addiction among TB cases from rural desert (16.1%) was compared with that in general population (7.1%) and the difference was found significant (X2 = 11.6, p > 0.001). The difference became a little more prominent after age adjustment. A case control analysis of matched pairs showed significant association between opium addiction and pulmonary tuberculosis (Odd's ratio = 2.61 and attributable risk = 0.099). Results were consistent in different age and ethnic groups. In cases with opium addiction, the addiction always preceded the pulmonary tuberculosis.


Asunto(s)
Narcóticos , Opio , Trastornos Relacionados con Sustancias/complicaciones , Tuberculosis Pulmonar/etiología , Adolescente , Adulto , Estudios de Casos y Controles , Humanos , India/epidemiología , Masculino , Prevalencia , Factores de Riesgo , Población Rural , Trastornos Relacionados con Sustancias/epidemiología , Tuberculosis Pulmonar/epidemiología
17.
Ann N Y Acad Sci ; 587: 59-69, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2113788

RESUMEN

Both macro- and micronutrients have been shown to affect resistance to tuberculosis, which is mediated by macrophages activated by T lymphocytes. Others have demonstrated inhibition of mycobacterial replication in macrophage cultures treated with vitamin D or retinoic acid. We examined the influence of dietary zinc and vitamin D on resistance to tuberculosis. Guinea pigs were fed diets containing varying levels of zinc or vitamin D, and infected 6 weeks later by the respiratory route with virulent Mycobacterium tuberculosis. Zinc-deficient guinea pigs had fewer circulating T cells and reduced tuberculin (PPD) hypersensitivity. The response of peritoneal exudate macrophages to the lymphokine MIF was impaired. Zinc deprivation did not influence disease resistance in BCG-vaccinated or nonvaccinated animals. Vitamin D deficiency adversely affected the tuberculin reaction and ability to control the infection. Lymphocytes from vitamin D-deprived animals did not proliferate normally when cultured with PPD. A diet supplemented with vitamin D enhanced T cell responses to PPD in vivo. These results suggest that zinc and vitamin D status affect immunity to tuberculosis.


Asunto(s)
Tuberculosis Pulmonar/inmunología , Vitamina D/fisiología , Zinc/fisiología , Animales , Vacuna BCG/farmacología , Cobayas , Inmunidad/efectos de los fármacos , Inmunidad/fisiología , Recuento de Leucocitos , Activación de Linfocitos/inmunología , Factores Inhibidores de la Migración de Macrófagos , Mycobacterium tuberculosis/aislamiento & purificación , Estado Nutricional , Deficiencia de Proteína/complicaciones , Formación de Roseta , Bazo/microbiología , Prueba de Tuberculina , Tuberculosis Pulmonar/etiología , Tuberculosis Pulmonar/prevención & control , Vitamina D/administración & dosificación , Deficiencia de Vitamina D/complicaciones , Zinc/deficiencia
18.
Eur J Clin Nutr ; 43(2): 117-28, 1989 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2707215

RESUMEN

We have compared the nutritional status of patients with lepromatous leprosy coinfected with pulmonary tuberculosis (18 cases) with that of lepromatous leprosy (239 cases) and of pulmonary tuberculosis (21 cases) and with that of healthy controls. There was a severe weight loss and reduction of skinfold thickness in the patients with pulmonary tuberculosis as well as in lepromatous patients with associated pulmonary tuberculosis, but not in patients with lepromatous leprosy. Levels in sera of diet-dependent proteins, such as albumin, prealbumin and retinol binding protein, were significantly decreased in all three groups of patients; on the other hand, levels of the diet-independent proteins, such as the immunoglobulins, were raised in all the groups, particularly in the pulmonary tuberculosis patients as compared with healthy controls. Serum transferrin levels were decreased only in the tuberculosis patients with or without lepromatous leprosy, but not in patients with leprosy alone. While haemoglobin levels decreased in all patient groups, serum iron concentrations were reduced most in lepromatous patients concomitantly infected with pulmonary tuberculosis. Serum ferritin levels increased in the sera of pulmonary tuberculosis and lepromatous leprosy patients, but was severely reduced in lepromatous patients with associated pulmonary tuberculosis. Mean serum zinc and calcium levels were decreased in all three groups of patients, while the serum copper concentration was increased in all of them compared with healthy controls. Also, inorganic phosphorus was elevated in tuberculosis and lepromatous patients coinfected with pulmonary tuberculosis, but not in lepromatous patients. Serum calcitonin levels were increased in all patient groups indicating an inverse correlation between serum calcium and calcitonin levels. This is the first comparative report describing the status of macro- and micronutrients in two most important mycobacterial diseases of the third world countries.


Asunto(s)
Lepra Lepromatosa/metabolismo , Trastornos Nutricionales/etiología , Tuberculosis Pulmonar/etiología , Adolescente , Adulto , Anciano , Calcitonina/sangre , Calcio/sangre , Cobre/sangre , Femenino , Hemoglobinas/análisis , Humanos , Lepra Lepromatosa/complicaciones , Masculino , Persona de Mediana Edad , Trastornos Nutricionales/sangre , Estado Nutricional , Fósforo/sangre , Tuberculosis Pulmonar/complicaciones , Zinc/sangre
19.
Probl Tuberk ; (9): 41-5, 1989.
Artículo en Ruso | MEDLINE | ID: mdl-2587549

RESUMEN

Characteristic features of pulmonary lesions after exposure to paraquat and various antioxidants were studied in albino rats. The antioxidants included dibunol, sodium thiosulfate and its combination with alpha-tocoferol. In the treated animals, there was a marked decrease in the areas affected by atelectasis and lower severity of elastofibrosis, involution of the connective tissue evident from its thinner fascicles and destruction of the collagenous and elastic fibers.


Asunto(s)
Antioxidantes/uso terapéutico , Pulmón/efectos de los fármacos , Paraquat/toxicidad , Animales , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Pulmón/patología , Atelectasia Pulmonar/inducido químicamente , Atelectasia Pulmonar/tratamiento farmacológico , Atelectasia Pulmonar/patología , Fibrosis Pulmonar/inducido químicamente , Fibrosis Pulmonar/tratamiento farmacológico , Fibrosis Pulmonar/patología , Ratas , Ratas Endogámicas , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/etiología , Tuberculosis Pulmonar/patología
20.
Calcif Tissue Int ; 37(6): 588-91, 1985 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-3937578

RESUMEN

Studies are described in a 53-year-old man with far-advanced pulmonary tuberculosis who developed transient increases in circulating 1,25 dihydroxyvitamin D (1,25(OH)2D) and hypercalcemia while on antituberculous treatment. Serial dilution of an extract of the patient's serum obtained while he was hypercalcemic displaced [3H]-1,25(OH)2D3 from chick intestinal receptor in a manner identical to authentic 1,25(OH)2D3. Serum 25-hydroxyvitamin D (25OHD) was suppressed during the abnormal elevation of serum 1,25(OH)2D. It is concluded that tuberculosis is another chronic granulomatous disease in which hypercalcemia may result from abnormal metabolism of vitamin D.


Asunto(s)
Dihidroxicolecalciferoles/sangre , Hipercalcemia/sangre , Tuberculosis Pulmonar/sangre , Animales , Creatinina/sangre , Humanos , Hipercalcemia/complicaciones , Masculino , Persona de Mediana Edad , Fósforo/sangre , Tuberculosis Pulmonar/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA